Hemangioblastoma

 

 

Uploaded: 2007-11-27, Updated: 2007-11-27

 

Related Case: Spinal mass

The Key Features

  • Association with VHL syndrome;

  • Locations: posterior cranial fossa » spinal cord;

  • Capillary vasculature, foamy stromal cells (true tumor cell), mast cells;

  • Stromal cells: inhibin+, NSE+, S100+, EGFR+; EMA−, CK−.

CLINICAL FEATURES

 

GROSS FINDINGS

 

MICROSCOPIC FINDINGS

 

SUBTYPES

 

DIFFERENTIAL DIAGNOSES

 
  • Metastatic renal cell carcinoma: similar histologic appearance and similar incidence in patients with von Hippel-Lindau syndrome.  On HE stained sections, renal cell carcinoma can have necrosis, mitosis and large nucleoli, features almost always absent on hemangioblastoma. Renal cell carcinoma is also immunoreactive for cytokeratin, CD10, and EMA, while hemangioblastoma is positive for inhibin, but negative for cytokeratin, CD10, and EMA. 

  • Other neoplasms with clear cell features include clear cell epdneymomas, clear cell meningioma with prominent vascularity, central liponeurocytoma of the cerebellum, and other metastatic clear cell neoplasms. Ependymomas are strongly are strongly immunoreactive for GFAP. Clear cell meningioma usually contains areas with features of classic meningothelial pattern and they are also immunoreactive for EMA. Central liponeurocytoma contains adipocytes and the neurocytoma cells are immunoreactive  for synaptophysin. Metastatic carcinoma are immunoreactive for cytokeratin and, often, EMA.

  • Capillary hemangioma: no vacuolated interstitial cells.

IMMUNOHISTOCHEMISTRY AND SPECIAL STAINS

 
  • The stromal cells stain strongly for S100, NSE, vimentin,  EGFR and PDGF-alpha and inhibin, and they are typically negative for EMA, cytokeratin, neurofilament, and synaptophysin.  In a small number of cases, the stromal cells express glial fibrillary acidic protein (GFAP)

  • The admixed capillaries  stain for with typical endothelial markers, CD31, CD34 and Factor-VIII.

ELECTRON MICROSCOPIC FINDINGS

 
  • Stromal cells: intracytoplasmic lipid droplets, microfilaments and SER/RER;

  • Endothelial cells: Weibel-Palade bodies.

CYTOGENETIC STUDIES

 
  • VHL gene mutation in VHL syndrome associated cases.

TREATMENT AND PROGNOSIS

 
  • Low recurrence risk if total resection.

  • Risk of multiple tumors in VHL with worse prognosis.

REFERENCES

 
  • AFIP, tumor of the central nervous system, series 4;

  • Rosai and Ackerman's Surgical Pathology, 9th edition;

  • http://moon.ouhsc.edu/kfung/JTY1/Com04/Com407-1-Diss.htm

  • http://www.emedicine.com/med/topic2991.htm